Literature DB >> 16233922

Prevalence of conventional risk factors in Jordanians with coronary heart disease: the Jordan Hyperlipidemia and Related Targets Study (JoHARTS).

Ayman J Hammoudeh1, Hatem Al-Tarawneh, Ahmad Elharassis, Jihad Haddad, Ziad Mahadeen, Nidal Badran, Mahmoud Izraiq, Eyas Al-Mousa.   

Abstract

BACKGROUND: The prevalence of the major conventional cardiovascular risk factors - cigarette smoking, diabetes mellitus, hypertension, and dyslipidemia - among coronary heart disease (CHD) patients in the Middle East has not been studied extensively. METHODS AND
RESULTS: The Jordan Hyperlipidemia And Related Targets Study (JoHARTS) evaluated the prevalence of the 4 conventional risk factors in 5000 individuals including 1692 (34%) women. CHD was present in 1534 (31%) individuals (1202 men and 332 women). Among CHD patients, at least one risk factor was present in the majority of men (95%) and women (96%). Compared with women who had CHD, men had significantly higher prevalence of smoking (45% vs. 11%, p < 0.0001) and low levels of high-density lipoprotein cholesterol (60% vs. 39%, p < 0.0001), and lower prevalence of diabetes (40% vs. 64%, p < 0.0001), hypertension (38% vs. 63%, p < 0.0001), and hypercholesterolemia (19% vs. 27%, p = 0.003). Diabetes was more prevalent among men and women with CHD than men and women without CHD (40% vs. 18% for men, and 64% vs. 24% for women p < 0.0001). Similarly, smoking was more prevalent in men and women with CHD than those without CHD (45% vs. 32% for men, and 11% vs. 7%, p < 0.0001). Low levels of high-density lipoprotein cholesterol were also more prevalent in men with CHD than those without CHD (60% vs. 51%, p < 0.001) and among women with CHD than those without CHD (39% vs. 24%, p = 0.0001). Prevalence rates of hypertension, hypercholesterolemia, and hypertriglyceridemia were not different among individuals with or without CHD.
CONCLUSION: These results further challenge claims that patients with CHD commonly lack conventional risk factors. The great majority (>95%) of CHD patients studied have at least one risk factor. Detection, evaluation and management of these factors are essential steps to control CHD in the region.

Entities:  

Mesh:

Year:  2005        PMID: 16233922     DOI: 10.1016/j.ijcard.2005.08.005

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  13 in total

1.  Hypertension risk assessment in the largest ethnic groups in Jordan.

Authors:  Kawkab Shishani; Rana Dajani; Yousef Khader
Journal:  J Immigr Minor Health       Date:  2013-02

2.  Prevalence, awareness, treatment, and control of hypertension among Arab Americans.

Authors:  Ayman Tailakh; Janet C Mentes; Donald E Morisky; Nancy A Pike; Linda R Phillips; Lorraine S Evangelista
Journal:  J Cardiovasc Nurs       Date:  2013 Jul-Aug       Impact factor: 2.083

Review 3.  Premature Myocardial Infarction in the Middle East and North Africa: Rationale for the Gulf PREVENT Study.

Authors:  Sagar B Dugani; Waheed Murad; Karisamae Damilig; Jean Atos; Eshraga Mohamed; Edward Callachan; Zareen Farukhi; Arshia Shaikh; Abubaker Elfatih; Salwa Yusef; Yousif M Hydoub; M Vinayaga Moorthy; Bassem Mora; Ahlam Alawadhi; Robin Issac; Abdulkarim Saleh; Arif Al-Mulla; Samia Mora; Alawi A Alsheikh-Ali
Journal:  Angiology       Date:  2019-05-26       Impact factor: 3.619

4.  Knowledge and beliefs about smoking and goals for smoking cessation in hospitalized men with cardiovascular disease.

Authors:  Rami Azmi Elshatarat; Nancy A Stotts; Marguerite Engler; Erika Sivarajan Froelicher
Journal:  Heart Lung       Date:  2013-01-03       Impact factor: 2.210

5.  Towards a portable-noninvasive blood pressure monitoring system utilizing the photoplethysmogram signal.

Authors:  Ahmad Dagamseh; Qasem Qananwah; Hiam Al Quran; Khalid Shaker Ibrahim
Journal:  Biomed Opt Express       Date:  2021-11-19       Impact factor: 3.732

6.  Eprosartan-based hypertension therapy, systolic arterial blood pressure and cognitive function: analysis of Middle East data from the OSCAR study.

Authors:  Ghazi Ahmad Radaideh; Patrick Choueiry; Amr Ismail; Elie Eid; Jean-Pascal Berrou; Armand Sedefdjian; Frank Sévenier; Atul Pathak
Journal:  Vasc Health Risk Manag       Date:  2011-08-01

7.  Alarming high prevalence of metabolic syndrome among Jordanian adults.

Authors:  Ahmad A Obeidat; Mousa N Ahmad; Fares H Haddad; Firas S Azzeh
Journal:  Pak J Med Sci       Date:  2015 Nov-Dec       Impact factor: 1.088

8.  Leptin and uric acid as predictors of metabolic syndrome in jordanian adults.

Authors:  Ahmad A Obeidat; Mousa N Ahmad; Fares H Haddad; Firas S Azzeh
Journal:  Nutr Res Pract       Date:  2016-04-26       Impact factor: 1.926

9.  Outcomes of Middle Eastern Patients Undergoing Percutaneous Coronary Intervention: The Primary Analysis of the First Jordanian PCI Registry.

Authors:  Imad A Alhaddad; Ramzi Tabbalat; Yousef Khader; Eyas Al-Mousa; Mahmoud Izraiq; Assem Nammas; Mohammad Jarrah; Akram Saleh; Ayman Hammoudeh
Journal:  Heart Views       Date:  2017 Jan-Mar

10.  Frequent mental distress, chronic conditions, and adverse health behaviors in the Behavioral Risk Factor Surveillance Survey, Jordan, 2007.

Authors:  Mohannad Al-Nsour; Meyasser Zindah; Adel Belbeisi; Italia V Rolle; Henry Walke; Tara Strine; Geraldine S Perry; Bassam Jarrar; Ali Mokdad
Journal:  Prev Chronic Dis       Date:  2013-08-22       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.